Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Olema Pharmaceuticals, Inc. | Director | Common Stock | 708K | $10.5M | $14.85 | Jun 4, 2024 | Indirect |
Akero Therapeutics, Inc. | Director | Common Stock | 800K | $492K | $0.62 | Dec 8, 2023 | Indirect |
Akero Therapeutics, Inc. | Director | Common Stock | 2.17K | $1.33K | $0.62 | Dec 8, 2023 | Direct |
Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 8, 2024 | Direct | ||
Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 23K | Jun 14, 2024 | Direct | ||
ALX ONCOLOGY HOLDINGS INC | Director | Stock option (right to buy) | 12K | Jun 11, 2021 | Direct |